DCGI Allows Usage Of Covishield Vaccine For 9 Months From Manufacture
Drug Controller General of India on March 31 extended the usage time limit of Oxford-AstraZeneca's COVID-19 vaccine Covishield. The vaccine earlier permitted usage for six months after the date of manufacture, can now be used for nine months from its manufacturing date. Writing to the Serum Institute of India, the DCGI stated that all details about the stock should be submitted to DCGI's office and Central Drugs Authority.
Tags: COVISHIELD, Serum Institute of India, Coronavirus Vaccines, DCGI
Courtesy: Times Now
Jharkhand Woman Allegedly Forced To Take COVID Vaccine Jab, Dies
A 72-year-old woman, Devmani Dev, from Jharkhand's Orsa Path village died on March 23, just two days after being administered with the COVID-19 vaccine. Devmani's grandson Ranbir Yadav has claimed that local health workers pressurized his grandmother by saying that if she avoided the inoculation then she would not be given ration and pension. However, the Latehar District Administration has denied the allegations and said that the deceased… read-more
Tags: Jharkhand, COVISHIELD, Latehar, Covid-19 Vaccination
Courtesy: The Indian Express
Centre Allows All 45+ For COVID Jab; Nixes Mandatory Health Certificate
The Centre, on March 23, announced to open COVID-19 vaccination for everyone above 45 years in its attempt to speed up the nationwide inoculation drive. Union Minister Prakash Javadekar clarified that people above 45-year-old will no longer require to produce co-morbidity certificates. The move came after the Centre widened the Covishield dosage gap from four to eight weeks on March 22. The government has requested several states to open… read-more
Tags: Central Government, Prakash Javadekar, COVISHIELD, Inoculation Drive
Courtesy: Hindustan Times
Centre Orders Increasing Gap Of Vaccine Interval To 4-8 Weeks
The Centre, on March 22, directed all states and union territories to increase vaccine dose interval from existing 4-6 weeks to 4-8 weeks. Notably, the recommendation based on the vaccine administration's expert committee is only for the 'Covishield' vaccine and not for 'Covaxin'. The Centre's decision is inspired by scientific evidence that shows protection against coronavirus is enhanced if Covishield's second dose is administered between 6… read-more
Tags: Central Government, COVISHIELD, Covaxin, Coronavirus
Courtesy: Business Standard
Billboards Displayed In Canada To Thank PM Modi For COVID-19 Vaccine
Billboards thanking PM Narendra Modi for the COVID-19 vaccine have been put up in Greater Toronto, Canada. The billboards read, "Thank You India and PM Narendra Modi for providing COVID vaccines to Canada. Long Live Canada-India Friendship." Moreover, Canadian PM Justin Trudeau also expressed his gratitude saying that if the world conquers COVID-19 "it would be significantly because of India's tremendous pharmaceutical capacity." Earlier, on… read-more
Tags: Canada, Toronto, PM Narendra Modi, COVISHIELD
Courtesy: Livemint
Pune Court Rejects Cutis' Suit Against Serum Institute Over "Covishield" Name
A Pune court has rejected Cutis Biotech’s claim seeking the Serum Institute of India to drop the use of trademark ‘Covishield’ for its COVID-19 vaccine. Rejecting Cutis’ application, the court observed that the company had approached it with "suppressed… read-more
Tags: Serum Institute of India, Cutis Biotech, COVISHIELD, lawsuit, trademark, civil court, High Court, Pune, Maharashtra
Courtesy: NDTV
1,000 Covishield Doses Found Frozen At Assam's Medical College
Assam's Silchar Medical College and Hospital witnessed a total of 1,000 doses of spoiled 'Covishield' vaccines due to extreme cold storage temperatures. While the ideal storage temperature for the vaccine is 2-8°C, the temperature of the storage facility at SMCH slumped to minus 5-6°C, freezing the vaccines. Instigating a probe into the matter, the state Health Minister Himanta Biswa Sarma said the lapses might have occurred probably due to… read-more
Tags: COVISHIELD, Vaccine Storage, Assam, Extreme Temperature Silchar Medical College and Hospital, Health Minister, Himanta Biswa Sarma, National Health Mission
Courtesy: The Times Of India
India Gifts 1.5 Lakh Serum Institute's 'Covishield' Vaccines To Bhutan
Strengthening India-Bhutan relationships, the Centre on January 20 dispatched 1.5 lakh doses of Covishield vaccine to Bhutan. Interestingly, Bhutan became the first foreign country to receive the vaccines developed by the Serum Institute of India. Earlier, throughout the COVID-19 pandemic, India has supplied medicines, medicinal equipment and essential commodities to Bhutan. Besides, India also repatriated over 2,000 Bhutanese nationals… read-more
Tags: India, Bhutan, COVISHIELD, COVID-Vaccine
Courtesy: Times Now
Maldives Becomes First Country To Receive India's Covishield Vaccine
After the government approved COVID Vaccine consignment, Maldives will become the first country to be aided by India's Covishield vaccine. Reportedly, the consignment, sufficient for the frontline workers and senior citizens of Maldives, will land at Velana International Airport, Malé in an Air-India flight on January 20. However, the Island is currently the largest COVID-19 assistance recipient in India's neighbourhood including medical… read-more
Tags: COVISHIELD, Covid -19, Coronavirus Vaccines, Maldives, Humanitarian Help
Courtesy: The Indian Express
4 More Vaccines Under Development, Says SII Executive Director
Executive Director of Serum Institute of India (SII), Suresh Jadhav, has informed that the company is currently working on four more covid-19 vaccines apart from Covishield. Suresh said, "Three others are in different stages of clinical studies while one is in the pre-clinical stage of the trial". Reportedly, SII has collaborated with US firms like Codagenix and Novavax inc aiming to produce 200 crore doses of vaccine.
Tags: SII, Suresh Jadhav, COVISHIELD, Coronavirus Vaccine
Courtesy: Business Insider